Lava Therapeutics B.V. announced the appointment of Benjamin Winograd as the company’s Chief Medical Officer. In this new role, Winograd will report to Steve Hurly, Chief Executive Officer, in their U.S. office, and oversee strategic direction of clinical operations, translational medicine and regulatory affairs. Winograd brings more than 35 years of experience within the pharmaceutical industry to Lava. He joins the company from Celgene, where he most recently served as the clinical research and development therapeutic area head for multiple myeloma.